AC Fluckiger

618 total citations
10 papers, 540 citations indexed

About

AC Fluckiger is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, AC Fluckiger has authored 10 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Genetics and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in AC Fluckiger's work include Chronic Lymphocytic Leukemia Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). AC Fluckiger is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). AC Fluckiger collaborates with scholars based in Israel and France. AC Fluckiger's co-authors include Jacques Banchereau, Isabelle Durand, Jacques Banchereau, Thierry Defrance, Pierre Garrone, P.A. Bryon, A Bussel, Sotto Jj, JP Magaud and Florence Malisan and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Annals of Oncology.

In The Last Decade

AC Fluckiger

10 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
AC Fluckiger Israel	8	380	274	180	112	103	10	540
Andrea Bürkle Germany	3	296 0.8×	330 1.2×	192 1.1×	161 1.4×	175 1.7×	3	550
L G Billips United States	8	463 1.2×	144 0.5×	89 0.5×	180 1.6×	137 1.3×	11	680
H Mellstedt Sweden	9	223 0.6×	225 0.8×	194 1.1×	154 1.4×	121 1.2×	16	501
Katherine Stephans United States	6	459 1.2×	214 0.8×	175 1.0×	196 1.8×	250 2.4×	7	702
Vadim Dyomin United States	11	126 0.3×	178 0.6×	217 1.2×	197 1.8×	190 1.8×	13	491
Katarina Dahlenborg Sweden	11	273 0.7×	136 0.5×	52 0.3×	168 1.5×	68 0.7×	13	523
Vasantha Brito‐Babapulle United Kingdom	15	283 0.7×	498 1.8×	457 2.5×	171 1.5×	233 2.3×	29	773
Jan‐Willem Vaandrager Netherlands	11	109 0.3×	200 0.7×	245 1.4×	219 2.0×	136 1.3×	16	519
M L Bloom United States	7	227 0.6×	334 1.2×	252 1.4×	62 0.6×	55 0.5×	8	415
Ellen J. van Gastel-Mol Netherlands	9	266 0.7×	95 0.3×	171 0.9×	57 0.5×	139 1.3×	12	442

Countries citing papers authored by AC Fluckiger

Since Specialization

Citations

This map shows the geographic impact of AC Fluckiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AC Fluckiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AC Fluckiger more than expected).

Fields of papers citing papers by AC Fluckiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AC Fluckiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AC Fluckiger. The network helps show where AC Fluckiger may publish in the future.

Co-authorship network of co-authors of AC Fluckiger

This figure shows the co-authorship network connecting the top 25 collaborators of AC Fluckiger. A scholar is included among the top collaborators of AC Fluckiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AC Fluckiger. AC Fluckiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Anderson, David E., Alona Zilberberg, Max J. Gordon, et al.. (2020). 1061P TCR and HLA analysis of patients in a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM). Annals of Oncology. 31. S724–S724. 1 indexed citations

Malisan, Florence, AC Fluckiger, Stephen Ho, et al.. (1996). B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro [see comments]. Blood. 87(2). 717–724. 48 indexed citations

Fluckiger, AC, Isabelle Durand, & Jacques Banchereau. (1994). Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells.. The Journal of Experimental Medicine. 179(1). 91–99. 134 indexed citations

Fluckiger, AC, Francine Brière, Gérard Zurawski, J M Bridon, & Jacques Banchereau. (1994). IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.. PubMed. 83(3). 397–403. 21 indexed citations

Fluckiger, AC, et al.. (1993). Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes.. The Journal of Experimental Medicine. 178(5). 1473–1481. 123 indexed citations

Banchereau, Jacques, et al.. (1993). Effects of interleukin 4 on human B-cell growth and differentiation. Research in Immunology. 144(8). 601–605. 7 indexed citations

Fluckiger, AC, et al.. (1992). Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood. 80(12). 3173–3181. 121 indexed citations

Fluckiger, AC, et al.. (1992). Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood. 80(12). 3173–3181. 9 indexed citations

Defrance, Thierry, AC Fluckiger, JF Rossi, et al.. (1992). Antiproliferative effects of interleukin-4 on freshly isolated non- Hodgkin malignant B-lymphoma cells. Blood. 79(4). 990–996. 34 indexed citations

10.

Defrance, Thierry, et al.. (1992). Antiproliferative effects of interleukin-4 on freshly isolated non- Hodgkin malignant B-lymphoma cells. Blood. 79(4). 990–996. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact